Statin therapy: having the good without the bad.
Liao
James K
JK
D000818:Animals; D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001057:Apolipoproteins E / Q000172:deficiency; D001161:Arteriosclerosis / Q000503:physiopathology; D003097:Collateral Circulation / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects; D006614:Hindlimb / Q000098:blood supply; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007511:Ischemia / Q000503:physiopathology; D051379:Mice; D018345:Mice, Knockout; D009369:Neoplasms / Q000098:blood supply; D009389:Neovascularization, Pathologic / Q000139:chemically induced; D018919:Neovascularization, Physiologic / Q000187:drug effects
D000924:Anticholesteremic Agents; D001057:Apolipoproteins E; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors